These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 2760254)
1. The renal function and blood pressure effects of dilevalol in the normotensive and hypertensive elderly. Clifton GG; Cook ME; Poland M; Wallin JD J Clin Pharmacol; 1989 Jul; 29(7):603-8. PubMed ID: 2760254 [TBL] [Abstract][Full Text] [Related]
2. Effects of dilevalol on renal function. Clifton GG; Cook ME; Wallin JD Am J Cardiol; 1989 Jun; 63(19):75I-78I. PubMed ID: 2729128 [TBL] [Abstract][Full Text] [Related]
3. Renal function effects of dilevalol, a nonselective beta-adrenergic blocking drug with beta-2 agonist activity. Cook ME; Wallin JD; Clifton GG; Poland M Clin Pharmacol Ther; 1988 Apr; 43(4):393-9. PubMed ID: 3356083 [TBL] [Abstract][Full Text] [Related]
4. Effects of dilevalol, an R, R-isomer of labetalol, on blood pressure and renal function in patients with mild-to-moderate essential hypertension. Baba T; Murabayashi S; Aoyagi K; Ishizaki T Eur J Clin Pharmacol; 1988; 35(1):9-15. PubMed ID: 2905992 [TBL] [Abstract][Full Text] [Related]
5. Effects of dilevalol (R,R-labetalol) compared with nifedipine on heart rate, blood pressure and muscle blood flow at rest and on exercise in hypertensive patients. Walley T; Tsao Y; Scott A; Mackay E; Vandenburg M; Breckenridge A Br J Clin Pharmacol; 1993 Jun; 35(6):623-8. PubMed ID: 8329290 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the renal effects of dilevalol and carteolol in patients with mild to moderate essential hypertension. Baba T; Murabayashi S; Tomiyama T; Takebe K Eur J Clin Pharmacol; 1990; 38(3):305-7. PubMed ID: 2187701 [TBL] [Abstract][Full Text] [Related]
8. Comparison of intravenous dilevalol with placebo in moderate hypertension. Winer N; Blasucci DJ; Medakovic M Clin Pharmacol Ther; 1989 Oct; 46(4):445-50. PubMed ID: 2551560 [TBL] [Abstract][Full Text] [Related]
9. Effects of dilevalol, metoprolol and atenolol on left ventricular mass and function in nonelderly and elderly hypertensive patients. Frishman WH; Glasser SP; Strom JA; Schoenberger JA; Liebson P; Poland MP Am J Cardiol; 1989 Jun; 63(19):69I-74I. PubMed ID: 2567114 [TBL] [Abstract][Full Text] [Related]
10. Antihypertensive activity and duration of action of dilevalol in hypertensive patients at rest and during exercise. A comparison with captopril. Fogari R; Poletti L; Tettamanti F; Cesana B; Savonitto S G Ital Cardiol; 1990 Apr; 20(4):309-15. PubMed ID: 2197158 [TBL] [Abstract][Full Text] [Related]
11. Multicenter comparison of dilevalol to placebo in patients with mild hypertension. Frishman WH; Schoenberger JA; Gorwit JI; Bedsole GD; Cubbon J; Poland MP Am J Hypertens; 1988 Jul; 1(3 Pt 3):295S-299S. PubMed ID: 3046631 [TBL] [Abstract][Full Text] [Related]
12. The safety and efficacy of once-daily dilevalol in patients with mild hypertension: a placebo-controlled study. Soberman J; Greenberg S; Frishman W J Clin Hypertens; 1987 Sep; 3(3):271-7. PubMed ID: 3312501 [TBL] [Abstract][Full Text] [Related]
13. Clinical and biological evaluation of dilevalol vasodilating properties in mild to moderate hypertension. Drici MD; Candito M; Ferrari E; Jacomet Y; Morand P; Lapalus P Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):361-5. PubMed ID: 1937998 [TBL] [Abstract][Full Text] [Related]
14. A multicenter double-blind study of the efficacy and safety of once and twice daily dilevalol compared to propranolol. Schoenberger JA; Wallin JD; Gorwit JI; Davidov ME; Michelson EL; Poland MP; Frishman WH Am J Hypertens; 1989 Nov; 2(11 Pt 1):840-6. PubMed ID: 2686711 [TBL] [Abstract][Full Text] [Related]
15. Dilevalol in severe hypertension. A multicenter trial of bolus intravenous dosing. Wallin JD; Cook ME; Fletcher E; Holtzman JL; Winer N; Gavras H; Grim CE; Ramanathan KB; Vidt DG; Johnson BF Arch Intern Med; 1989 Dec; 149(12):2655-61. PubMed ID: 2688585 [TBL] [Abstract][Full Text] [Related]
16. Comparison of dilevalol and enalapril administered once daily for mild hypertension. Rodriguez-Saavedra M; Zannad FM; Guerrero-Sierra J; Sack DW; Renaud H; Guiducci U; Edwards LD Am J Cardiol; 1989 Jun; 63(19):50I-53I. PubMed ID: 2543201 [TBL] [Abstract][Full Text] [Related]
17. Influence of beta 2 agonism and beta 1 and beta 2 antagonism on adverse effects and plasma lipoproteins: results of a multicenter comparison of dilevalol and metoprolol. Materson BJ; Vlachakis ND; Glasser SP; Lucas C; Ramanathan KB; Ahmad S; Morledge JH; Saunders E; Lutz LJ; Schnaper HW Am J Cardiol; 1989 Jun; 63(19):58I-63I. PubMed ID: 2567113 [TBL] [Abstract][Full Text] [Related]
18. Renal hemodynamics and reduction of proteinuria by a vasodilating beta blocker versus an ACE inhibitor. Erley CM; Harrer U; Krämer BK; Risler T Kidney Int; 1992 May; 41(5):1297-303. PubMed ID: 1614045 [TBL] [Abstract][Full Text] [Related]
19. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension. Wong GW; Laugerotte A; Wright JM Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578 [TBL] [Abstract][Full Text] [Related]
20. Intravenous dilevalol in the treatment of severe hypertension. Bursztyn M; Gavras I; Blasucci DJ; Gavras H J Cardiovasc Pharmacol; 1989 May; 13(5):799-802. PubMed ID: 2472530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]